Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

This article explains how FDA Inspection Preparation shapes GMP compliance by linking Quality Management Systems with CAPA, Data Integrity, and Risk Management. It highlights common inspection gaps and shows how companies improve readiness and reduce Form 483 findings.